TerminatedNot Applicable

Collection of Blood for Gene Expression/Genomic Studies in Individuals With Diabetes (Qatar)

Stopped: Lack of funding.

Qatar450 participantsStarted 2009-06

Plain-language summary

This protocol is designed to gather a small amount of blood for extraction of DNA for the study of the genetic basis of diabetes. The study population will include individuals with known diabetes, and controls without diabetes. Investigators aim to understand the genetics of diabetes, and will use the cells and serum from this blood to perform genotyping and gene expression studies of individuals with diabetes and relevant controls.

Who can participate

Age range18 Years – 90 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Diabetes group Inclusion criteria: * Must provide informed consent * Males and females, age 18 years and older * Documented evidence of diabetes using at least one of the following: (1) blood tests consistent with Type-II diabetes; (2) oral glucose tolerance tests consistent with Type-II diabetes; (3) subject taking medication to treat Type-II diabetes. Exclusion criteria: * Individual refuses consent * Pregnant females with gestational diabetes * Type-I diabetes Normal control group Inclusion Criteria: * Must provide informed consent * Males or females ages 18 years and older * Resolved gestational diabetes Exclusion Criteria: * Individual refuses consent. * Individuals with history of diabetes.

Trial details

NCT IDNCT01172743

SponsorWeill Medical College of Cornell University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2020-07

View on ClinicalTrials.gov More Diabetes Mellitus trials